FDA Inspection 1192736 — Wyeth Pharmaceutical Division of Wyeth Holdings LLC
The FDA completed an inspection of Wyeth Pharmaceutical Division of Wyeth Holdings LLC on November 18, 2022 in Sanford, NC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- November 18, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Sanford, NC (United States)